Susceptibility and resistance emergence studies with macrolides
- 28 February 1999
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 11, S15-S21
- https://doi.org/10.1016/s0924-8579(98)00099-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Quantitative Structure−Activity Relationships among Macrolide Antibacterial Agents: In Vitro and in Vivo Potency against Pasteurella multocidaJournal of Medicinal Chemistry, 1997
- Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in childrenJournal of Antimicrobial Chemotherapy, 1996
- Concentrations of azithromycin in tonsillar and/or adenoid tissue from paediatric patientsJournal of Antimicrobial Chemotherapy, 1996
- Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens (infection 23 [1995] 316–321)Infection, 1996
- Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogensInfection, 1995
- Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Effects of environmental factors on the in vitro potency of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.The Journal of Antibiotics, 1987
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987